Lista de obras -

Analysis of RCAS1 immunoreactivity within hydatidiform mole cells and decidual cells according to the applied therapeutic strategy: surgery or surgery followed by chemotherapy

artículo científico publicado en 2012

Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment

artículo científico publicado en 2013

Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients

artículo científico publicado en 2018

Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells - is a new era coming?

artículo científico publicado en 2018

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

scientific article published on 02 September 2020

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer

scientific article published on 03 April 2019

Coumarins modulate the anti-glioma properties of temozolomide

scientific article published on 21 May 2020

Decreased lactoferrin levels in peritoneal fluid of women with minimal endometriosis

artículo científico publicado en 2006

Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer

artículo científico publicado en 2008

Disrupted iron metabolism in peritoneal fluid may induce oxidative stress in the peritoneal cavity of women with endometriosis

scientific article published on 11 July 2017

Does the patients age at cancer diagnosis affect microvessels density in uterine sarcoma tissues?

artículo científico publicado en 2017

Endometriosis in adolescents

artículo científico publicado en 2013

Evaluation of IL-10 and TGF-β levels and myeloid and lymphoid dendritic cells in ovarian cancer patients

artículo científico publicado el 1 de junio de 2011

Evaluation of myeloid and lymphoid dendritic cells in peritoneal fluid in women with non-malignant ovarian tumors

artículo científico publicado en 2003

Gender Dysphoria Disrupting the Course of Treatment of a Recurrent Juvenile Granulosa Cell Tumor in an Adolescent Female: A Case Report

artículo científico publicado en 2020

Identification of myeloid dendritic cells in peritoneal fluid by flow cytometry

artículo científico publicado el 1 de febrero de 2003

Increased levels of oxidative stress markers in the peritoneal fluid of women with endometriosis

artículo científico publicado en 2013

Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.

artículo científico publicado en 2017

Investigation of glutathione concentrations in peritoneal fluid from women with and without endometriosis.

artículo científico publicado en 2003

Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment ⬇️

artículo científico

Leptin is not involved in the pathophysiology of endometriosis-related infertility

artículo científico publicado en 2005

Low-density lipoproteins oxidation and endometriosis

artículo científico publicado en 2013

Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients

artículo científico publicado en 2015

Management of uterine leiomyosarcoma

artículo científico publicado en 2016

Peritoneal immune system in patients with advance epithelial ovarian cancer

artículo científico publicado en 2011

Phenotype of dendritic cells generated from peripheral blood monocytes of patients with ovarian cancer.

artículo científico publicado en 2010

Potentilla alba Extracts Affect the Viability and Proliferation of Non-Cancerous and Cancerous Colon Human Epithelial Cells

artículo científico publicado en 2020

Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer

artículo científico publicado en 2020

Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients

artículo científico publicado en 2020

Quercetin and sorafenib as a novel and effective couple in programmed cell death induction in human gliomas

artículo científico publicado en 2013

Relationship between RANTES and dendritic cells in ovarian cancer patients

artículo científico publicado en 2011

SDF-1alpha/CXCL12 and dendritic cells in ovarian cancer microenvironment

artículo científico publicado el 1 de junio de 2011

Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment

artículo científico publicado en 2013

Subpopulations of peripheral blood dendritic cells during chemotherapy of ovarian cancer

artículo científico publicado en 2007

Temozolomide and sorafenib as programmed cell death inducers of human glioma cells.

artículo científico publicado en 2017

Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line.

artículo científico publicado en 2010

Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy

scientific article published on 21 February 2020

The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study

artículo científico publicado en 2019

The role of dendritic cells in cytotoxic immune response regulation in ovarian cancer micro-environment.

artículo científico publicado en 2008

The role of iron metabolism and oxidative stress in the pathogenesis of endometriosis

artículo científico publicado en 2013

Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges

artículo científico publicado en 2016

[Assessment of regulatory T cells, cytotoxic lymphocytes and dendritic cells in ovarian cancer patients before and after menopause]

artículo científico publicado en 2016

[Characterization of chosen pro-angiogenic factors and anti-angiogenic therapies in ovarian cancer]

artículo científico publicado en 2018

[Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer]

artículo científico publicado en 2012

[Expression of lymphangiogenesis marker neuropilin-1 in different types of ovarian cancer]

artículo científico publicado en 2010

[Expression of tumor necrosis factor-alpha (TNF-alpha) on peritoneal fluid mononuclear cells in women with endometriosis]

scientific article published on 01 January 2008

[Ferritin levels in the peritoneal fluid--a new endometriosis marker?].

artículo científico publicado en 2006

[Lymphangiogenesis in cancerous tumours]

artículo científico publicado en 2008

[Lymphocyte activation markers in patients with ovarian cancer]

artículo científico publicado en 2012

[Peritoneal fluid iron levels in women with endometriosis].

artículo científico publicado en 2010

[Selected mechanisms inducing resistance to immunotherapy in patients with ovarian cancer]

artículo científico publicado en 2019

[The meaning of PD-1/PD-L1 pathway in ovarian cancer pathogenesis].

artículo científico publicado en 2018

[The prognostic value of selected immunological factors in ovarian cancer patients].

artículo científico publicado en 2015

[Why ovarian cancer cells escape from immune surveillance?]

artículo científico publicado en 2017

[YB-1 protein expression in ovarian cancer].

artículo científico publicado en 2006

Lista de obras de

Analysis of RCAS1 immunoreactivity within hydatidiform mole cells and decidual cells according to the applied therapeutic strategy: surgery or surgery followed by chemotherapy

Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment

Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients

Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells - is a new era coming?

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer

Coumarins modulate the anti-glioma properties of temozolomide

Decreased lactoferrin levels in peritoneal fluid of women with minimal endometriosis

Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer

Disrupted iron metabolism in peritoneal fluid may induce oxidative stress in the peritoneal cavity of women with endometriosis

Does the patients age at cancer diagnosis affect microvessels density in uterine sarcoma tissues?

Endometriosis in adolescents

Evaluation of IL-10 and TGF-β levels and myeloid and lymphoid dendritic cells in ovarian cancer patients

Evaluation of myeloid and lymphoid dendritic cells in peritoneal fluid in women with non-malignant ovarian tumors

Gender Dysphoria Disrupting the Course of Treatment of a Recurrent Juvenile Granulosa Cell Tumor in an Adolescent Female: A Case Report

Identification of myeloid dendritic cells in peritoneal fluid by flow cytometry

Increased levels of oxidative stress markers in the peritoneal fluid of women with endometriosis

Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.

Investigation of glutathione concentrations in peritoneal fluid from women with and without endometriosis.

Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment ⬇️

Leptin is not involved in the pathophysiology of endometriosis-related infertility

Low-density lipoproteins oxidation and endometriosis

Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients

Management of uterine leiomyosarcoma

Peritoneal immune system in patients with advance epithelial ovarian cancer

Phenotype of dendritic cells generated from peripheral blood monocytes of patients with ovarian cancer.

Potentilla alba Extracts Affect the Viability and Proliferation of Non-Cancerous and Cancerous Colon Human Epithelial Cells

Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer

Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients

Quercetin and sorafenib as a novel and effective couple in programmed cell death induction in human gliomas

Relationship between RANTES and dendritic cells in ovarian cancer patients

SDF-1alpha/CXCL12 and dendritic cells in ovarian cancer microenvironment

Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment

Subpopulations of peripheral blood dendritic cells during chemotherapy of ovarian cancer

Temozolomide and sorafenib as programmed cell death inducers of human glioma cells.

Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line.

Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy

The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study

The role of dendritic cells in cytotoxic immune response regulation in ovarian cancer micro-environment.

The role of iron metabolism and oxidative stress in the pathogenesis of endometriosis

Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges

[Assessment of regulatory T cells, cytotoxic lymphocytes and dendritic cells in ovarian cancer patients before and after menopause]

[Characterization of chosen pro-angiogenic factors and anti-angiogenic therapies in ovarian cancer]

[Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer]

[Expression of lymphangiogenesis marker neuropilin-1 in different types of ovarian cancer]

[Expression of tumor necrosis factor-alpha (TNF-alpha) on peritoneal fluid mononuclear cells in women with endometriosis]

[Ferritin levels in the peritoneal fluid--a new endometriosis marker?].

[Lymphangiogenesis in cancerous tumours]

[Lymphocyte activation markers in patients with ovarian cancer]

[Peritoneal fluid iron levels in women with endometriosis].

[Selected mechanisms inducing resistance to immunotherapy in patients with ovarian cancer]

[The meaning of PD-1/PD-L1 pathway in ovarian cancer pathogenesis].

[The prognostic value of selected immunological factors in ovarian cancer patients].

[Why ovarian cancer cells escape from immune surveillance?]

[YB-1 protein expression in ovarian cancer].